Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
System Usability Scale [ Time Frame: 2019.04.01~2019.06.30 ]
It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. And also we can know the sanctification of the patient with ALS and their caregiver.
Secondary Outcome Measures :
Amyotrophic Lateral Sclerosis Specific Quality of Life Instrument-Revised, ALSSQOL-R [ Time Frame: 2019.04.01~2019.06.30 ]
ALSSQOL-R is a 50 item instrument that measures overall quality of life (QOL) and six specific domains for individuals with ALS.
Taiwanese Depression Questionnaire, TDQ [ Time Frame: 2019.04.01~2019.06.30 ]
The TDQ is a culturally relevant questionnaire, which is adaptable for screening depressive people in the local communities.
Caregiver Burden Scale [ Time Frame: 2019.04.01~2019.06.30 ]
The burden experienced by family caregivers is the most important caregiver-related variable in care at home of a chronically-ill person. The extent of subjective burden has significant impact on the emotional and physical health of the family caregiver, and even influences the mortality of spouse caregivers. It affects the way the family caregiver deals with the care-receiver and determines the time of institutionalization.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
20 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Participants with ALS were recruited from ALS clinics(Taipei Veterans General Hospital, Taiwan, R.O.C),20 participants. Participants were eligible for this study if they were diagnosed with definite, probable, probable laboratory-supported, or possible ALS according to the criteria (Brooks et al., 2000).
Escorial revised criteria (Brooks et al., 2000),The diagnosis of ALS requires:
(A) the presence of:
(A:1) evidence of lower motor neuron (LMN) degeneration by clinical, electrophysiological or neuropathologic examination (A:2) evidence of upper motor neuron (UMN) degeneration by clinical examination, and
(A:3) progressive spread of symptoms or signs within a region or to other regions, as determined by history or examination, together with: (B) the absence of (B:1) electrophysiological or pathological evidence of other disease processes that might explain the signs of LMN and/or UMN degeneration, and (B:2) neuroimaging evidence of other disease processes that might explain the observed clinical and electrophysiological signs.
If they were Taiwanese and used traditional Chinese(Mandarin).
If they were older than age 20 years.
If they had been diagnosed with frontotemporal dementia, severe depression, or schizophrenia.
If they cannot see the communication board after correction.
If they cannot complete the questionnaire with researchers or family members help.